Hackensack Meridian Health is partnering with Canary Health, which uses a proprietary machine learning model to evaluate digital biomarkers in human voices to interpret or predict outcomes. related to health. This will allow Hackensack Meridien to accelerate artificial intelligence technology for healthcare.
WHY IT IMPORTANT
According to Thursday’s announcement, Canary Speech’s patented technology tracks health factors “quickly, non-invasively and accurately.”
Developed by the neuro-linguistic AI team behind Amazon Alexa, Canary Speech aims to provide real-time proactive screening using algorithms built to enhance standard clinical assessments. standards such as GAD7 for anxiety and PHQ8 for depression.
The company uses machine learning technology to model both the acoustic and linguistic characteristics of human voices and speech, and aims to provide clinical-grade screening to detect changes in status. emotional health status and mental health decline in real time.
Hackensack Meridian says the tool’s vocal score can replace subjective measurements with “objective, workable” care plans.
Canary Speech is also working on voice assessment for diseases like Huntington, Alzheimer’s and Parkinson’s as well as PTSD and other conditions.
Dr Ihor Sawczuk, academic, research and innovation chair of Hackensack Meridian Health and founding president of Hackensack Meridian Health Institute, said: “This type of investment is a step forward. Smart, forward-looking strategy.
TREND TO BIGGER
Even in everyday and seemingly emotionless conversation, the human voice can reveal clues – in the pattern, inflection, and timing of those words – to both emotional states and physiology of an individual.
In December, Grace Chang, co-founder and CEO of Kintsugi, explained how new deep learning and machine learning-based speech biomarker technology is being implemented in healthcare systems and organizations paid organizations to identify clinical signs of depression and anxiety and improve access to mental health services.
Chang says thousands of tests during development show that what someone says is not as important as how they say it.
In a demo on HIMSSTV, Chang showed how the software tool – which protects privacy, delivers real-time results, and is language-independent – and the API architecture can be integrated into telehealth systems.
At the start of the virtual care session, the patient is asked to consent to be recorded for evaluation. Through the doctor’s visit, the technology determines that there may be a risk of more severe depression or anxiety and flags the clinician.
“This then gives them the opportunity to provide mental health services to the patient that the patient may not have known were necessarily being provided under their plan, and which could then be revealed.” appropriate program based on their level of depression or anxiety,” explains Chang.
The demo shows a visit to discuss a patient’s back pain. The clinician and patient discussed her physical experience when the tool provided GAD7 and PHQ8 scores, then encouraged her clinician to ask more questions about how she was feeling. about it and offer to recommend her.
ON PROFILE
“This is a fascinating innovation and we look forward to supporting a promising way to leverage technology for health,” said Robert C. Garrett, CEO of Hackensack Meridian Health.
“Artificial intelligence is impacting every aspect of modern life, and our medical network wants to help accelerate the efforts of companies like Canary Speech.”
Andrea Fox is the senior editor of Healthcare IT News.
Email: [email protected]
Healthcare IT News is a publication of HIMSS Media.
